Financial Data and Key Metrics Changes - Gross investment income for Q1 2025 was $11.9 million, a decrease from $12.7 million in Q4 2024 [11] - Net investment income was $7.6 million or $0.34 per share, compared to $8.0 million or $0.35 per share in the previous quarter [12] - Net expenses were $4.3 million, slightly down from $4.4 million in the last quarter [12] - Net assets at quarter end were $301 million, with NAV per share at $13.19 [12] Business Line Data and Key Metrics Changes - The company has 31 portfolio companies, with 21% of the portfolio invested outside of cannabis [12] - The average debt position size is 3% of the debt portfolio, with 76% of the portfolio being floating rate [13] - The gross weighted average yield on company debt investments is approximately 16.6% [13] Market Data and Key Metrics Changes - The company has originated $52.8 million in gross fundings since October 1, 2024, with $32.3 million committed and $20.8 million funded in Q1 2025 [7] - The pipeline includes approximately $590 million in potential debt transactions across 35 unique companies, with $462 million in cannabis opportunities and $128 million in non-cannabis investments [16] Company Strategy and Development Direction - The company focuses on lending to cannabis companies and other underserved markets, aiming to deploy capital with differentiated risk-reward profiles [5] - The strategy includes maintaining a disciplined underwriting approach and being selective with borrowers to build durable investment portfolios [19] - The company aims to grow its dividend component as it scales its platform, having declared a total of $1.27 in dividends over the last four quarters [8] Management's Comments on Operating Environment and Future Outlook - Management believes the outlook for common sense reforms in the cannabis industry is positive, but the timing remains unpredictable [10] - The company is positioned well for 2025, focusing on proven operators and strong markets to support growth initiatives [10] - Management emphasizes a long-term view of partnership building with operators, regardless of broader market conditions [23] Other Important Information - The company has no non-accruals compared to an industry average of 3.9% [7] - A new $100 million credit facility was closed during the quarter, providing ample liquidity for future investments [14] Q&A Session Summary Question: General macro outlook and deployment readiness - The company maintains a focus on individual state markets rather than the broader U.S. cannabis industry, allowing for disciplined deployment of capital [23][25] Question: Pipeline activity comparison to previous quarters - There is no significant difference in the ratio of cannabis to non-cannabis investments, with fluctuations being ordinary [26] Question: Flexibility to increase the credit facility - The company sees room to grow its senior secured credit facility and add modest unsecured notes in a disciplined manner [27] Question: Debt leverage threshold - The company expects to remain well below industry averages for debt leverage in the foreseeable future [28] Question: Dividend growth expectations - The company does not provide specific dividend guidance but will distribute nearly all of its income by the end of the year [30]

Group 1 - FS KKR Capital's quarterly earnings met expectations, indicating stable financial performance [1] - The quality of FS KKR Capital's balance sheet improved quarter-over-quarter, suggesting enhanced financial health [1] - The company supported its dividend through net investment income, reflecting strong operational performance [1] Group 2 - FS KKR Capital is actively growing its portfolio through new investments, indicating a strategic focus on expansion [1]

Financial analyst by day and a seasoned investor by passion, I've been involved in the world of investing for over 15 years and honed my skills in analyzing lucrative opportunities within the market.I specialize in uncovering high quality dividend stocks and other assets that offer potential for long term-growth that pack a serious punch for bill-paying potential. I use myself as an example that with a solid base of classic dividend growth stocks, sprinkling in some Business Development Companies, REITs, an ...

Financial Data and Key Metrics Changes - The first quarter results for 2025 were disappointing, with GAAP net investment income and core NII at $6,800,000 or $0.02 per share, down from $8,000,000 or $0.03 per share in Q4 2024 [6][19] - NAV per share decreased by approximately 1.6% to $12.11 from the prior quarter, impacted by net realized losses and markdowns totaling $2,600,000 [6][19] - The weighted average effective yield on income-producing debt investments decreased to 12.1% from 12.5% in the previous quarter [9][19] Business Line Data and Key Metrics Changes - Gross capital deployments in Q1 totaled $45,500,000, with net deployments of $26,100,000 after repayments and sales of $19,400,000 [6][9] - The portfolio mix at the end of Q1 was approximately 90.3% first lien, senior secured debt, with a mix of 2:3 sponsor to non-sponsor deals [8][9] - Nonaccrual investments increased to 8.8% of the debt portfolio from 7.2% in the prior quarter [13][19] Market Data and Key Metrics Changes - The STRS JV portfolio had an aggregate fair value of $310,200,000, with an average effective yield of 10.8%, down from 11.1% in Q4 [9][21] - The lending market has seen increased volatility, with a 25 to 50 basis point increase in direct lending market prices, although most of that premium has dissipated [15][19] - The M&A market has slowed significantly, with many deals being put on hold due to negative sentiment and tariff negotiations [14][45] Company Strategy and Development Direction - The company continues to focus on the non-sponsor market, where there are better risk-return profiles and less competition [16][19] - A new coverage region was added in Nashville, Tennessee, to enhance non-sponsor and off-the-run sponsor origination capabilities [16][19] - The company is actively monitoring tariff risks and has expanded its analysis to include other countries with potential tariffs [11][19] Management's Comments on Operating Environment and Future Outlook - Management noted that challenges in the quarter were more company-specific rather than related to the overall economy, with no signs of a recession yet in the portfolio [10][19] - The company expects a decent amount of refinancing activity in the second half of the year as prepayment penalties on higher-rate deals expire [51][19] - Management is cautious about the environment for deal closures in Q3, anticipating a relative quiet period [46][19] Other Important Information - The company declared a first-quarter distribution of $0.03 per share, consistent with the prior quarter, and will continue to evaluate quarterly distributions based on core earnings power [24][19] - Cash resources at the end of Q1 were approximately $19,600,000, with an asset coverage ratio of 177.2%, above the minimum requirement [22][19] Q&A Session Summary Question: Update on Telestream and its return to accrual status - Management indicated progress on restructuring Telestream, hoping to complete it by May, which would allow a portion of the existing debt to return to cash-paying status [28][19] Question: Insights on dividend and spillover income - Spillover income was approximately $28,400,000, with a current dividend run rate equating to about $8,950,000 in distributions, highlighting a shortfall in Q1 [39][19] Question: Market conditions regarding bid-ask spreads - Management noted that good companies without significant risks are trading at high multiples, while those with recession or tariff risks are seeing buyers being cautious [44][19] Question: Expectations on repayment activity - Management observed a slowdown in repayment activity due to recent market volatility, with a light visible repayment pipeline currently [53][19]

WhiteHorse Finance, Inc. Earnings Presentation Quarter Ended March 31, 2025 NASDAQ: WHF (Common Stock) NASDAQ: WHFCL (7.875% Notes due 2028) Important Information and Forward Looking Statements References in this presentation to "WHF", "WhiteHorse Finance", "we", "us", "our" and "the Company" refer to WhiteHorse Finance, Inc. This presentation and the information and views included herein do not constitute investment advice, or a recommendation or an offer to enter into any transaction with the Company or a ...

Together with Blackstone Secured Lending Fund ( BXSL ) , which I covered this month, Hercules Capital Inc. (NYSE: HTGC ) is my preferred choice in the market for business development companies right now, primarily because the BDC offers passive investors a solidA financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news ...

Core Insights - Blue Owl Capital Corp. (NYSE: OBDC) demonstrated resilience in the first quarter earnings, showcasing robust net investment income despite a challenging and volatile market [1] - The company successfully grew its portfolio value, indicating strong performance in a difficult economic environment [1] Financial Performance - The first quarter earnings report highlighted the company's ability to maintain strong net investment income [1] - The growth in portfolio value reflects the company's strategic positioning and adaptability in the current market conditions [1]

Financial Data and Key Metrics Changes - Runway Growth Finance reported total investment income of $35.4 million and net investment income of $15.6 million for Q1 2025, compared to $33.8 million and $14.6 million in Q4 2024, respectively [5][18] - The net asset value (NAV) per share decreased by 2.2% to $13.48 from $13.79 at the end of Q4 2024 [17] - The total investment portfolio's fair value decreased by 6.7% from $1.08 billion in Q4 2024 to $1 billion in Q1 2025 [17] Business Line Data and Key Metrics Changes - The weighted average portfolio risk rating remained stable at 2.33, indicating consistent credit quality [16] - The loan portfolio is primarily composed of first lien senior secured loans, with 97% of assets being floating rate [17][18] - The dollar weighted loan to value ratio increased from 28% to 29.1% [17] Market Data and Key Metrics Changes - The venture capital landscape has shifted, with a slowdown in fundraising and a focus on profitability over growth, impacting deal activity [11][12] - The company noted that healthcare lending has been softer, reflecting broader market caution [26][28] Company Strategy and Development Direction - The company aims to optimize its portfolio and expand origination channels following its merger with BC Partners [6][9] - A strategic focus on credit-first underwriting practices is intended to ensure long-term shareholder value [8] - The company is positioned to benefit from a diversified portfolio that mitigates risk [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to navigate ongoing market volatility and emphasized a focus on sustainable growth [12][61] - The sentiment in the venture ecosystem is shifting, with companies needing to demonstrate growth to attract investment [12][13] Other Important Information - The company has a new stock repurchase program approved for $25 million, reflecting management's belief in the stock's undervaluation [22] - A regular distribution of $0.33 per share and a supplemental dividend of $0.02 per share were declared for Q2 2025 [22] Q&A Session Summary Question: Comments on healthcare lending and its slowdown - Management noted that healthcare remains a core focus, but the current quarter has shown a softer lending environment [26][28] Question: Update on the investment pipeline - The pipeline is currently seeing a high percentage of refinances, with ongoing cautiousness in credit approaches [29][32] Question: Context on NII trends and dividend declaration - The supplemental dividend is lower due to a strategic decision to build NAV rather than payout excess earnings [35][37] Question: Trends in private credit market - There is an improvement in the structure of the pipeline, with better terms and lower leverage asks [42][44] Question: Highlights of realized gains and unrealized depreciation - Realized gains were driven by the sale of Gynasonics, while depreciation was influenced by performance and market multiples [50][52]

Financial Data and Key Metrics Changes - For Q1 2025, total investment income was $35.4 million, and net investment income was $15.6 million, compared to $33.8 million and $14.6 million in Q4 2024, respectively [5][18] - The net asset value (NAV) per share decreased by 2.2% to $13.48 from $13.79 at the end of Q4 2024 [17] - The total investment portfolio's fair value decreased by 6.7% from $1.08 billion in Q4 2024 to $1 billion in Q1 2025 [17] Business Line Data and Key Metrics Changes - The weighted average portfolio risk rating remained stable at 2.33, indicating consistent credit quality [16] - The loan portfolio is primarily composed of first lien senior secured loans, with 97% being floating rate assets [17][18] - The dollar-weighted average annualized yield on the debt portfolio increased to 15.4% in Q1 2025 from 14.7% in Q4 2024 [18] Market Data and Key Metrics Changes - The company executed three investments in existing portfolio companies totaling $50.7 million in funded loans during Q1 2025 [6][16] - The company noted a cautious approach in the healthcare lending sector, reflecting broader market conditions [26][28] Company Strategy and Development Direction - The company aims to optimize its portfolio and expand origination channels following its merger with BC Partners [5][7] - A strategic focus on credit-first underwriting practices is intended to ensure long-term shareholder value, even if it results in slower portfolio growth [8][9] - The company is positioned to benefit from a strategic focus that diversifies its portfolio and mitigates risk [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate ongoing market volatility and emphasized a focus on sustainable growth [12][61] - The management team highlighted a shift in venture-backed companies towards profitability and reduced cash burn, indicating a more cautious investment environment [11][12] - The company anticipates muted deal activity in 2025 but believes there will be a need for non-dilutive growth capital in the future [13] Other Important Information - The company extended its credit facility with KeyBank by three years and restructured its privately placed senior unsecured notes [20] - A new stock repurchase program of $25 million was approved, reflecting management's confidence in the company's valuation [22] - A regular distribution of $0.33 per share and a supplemental dividend of $0.02 per share were declared for Q2 2025 [22] Q&A Session Summary Question: Comments on healthcare lending and its slowdown - Management noted that healthcare lending has been softer and slower, reflecting cautious market conditions [26][27] Question: Update on the investment pipeline - The pipeline is currently seeing a mix of refinances and new opportunities, with a focus on ensuring appropriate structure and pricing [29][30] Question: Trends in net investment income (NII) and dividend declaration - The supplemental dividend for Q2 is lower due to a strategic decision to build NAV rather than prioritize dividend payouts [35][36] Question: Impact of private credit market conditions on pipeline - There is an improvement in the structure of the pipeline, with lower asks in terms of leverage and maintenance of quality covenants [42][43] Question: Highlights of realized gains and unrealized portfolio depreciation - Realized gains were driven by the sale of Gynasonics, while depreciation was influenced by performance and market multiples [50][52]

Financial Data and Key Metrics Changes - Total investment income for Q1 2025 was $35.4 million, an increase from $33.8 million in Q4 2024, while net investment income rose to $15.6 million from $14.6 million in the previous quarter [5][18] - The fair value of the total investment portfolio decreased to $1 billion, down 6.7% from $1.08 billion in Q4 2024 and down 1.2% from $1.02 billion in the same period last year [17] - Net assets decreased to $503.3 million from $514.9 million at the end of Q4 2024, with NAV per share falling to $13.48, a decrease of 2.2% [17] Business Line Data and Key Metrics Changes - The loan portfolio primarily consists of first lien senior secured loans, with 97% of assets being floating rate [17] - The dollar weighted loan to value ratio increased from 28% to 29.1% [17] - The debt portfolio generated a dollar weighted average annualized yield of 15.4% for Q1 2025, compared to 14.7% in Q4 2024 [18] Market Data and Key Metrics Changes - The first quarter of 2025 was characterized by a cautious market environment, with a noted slowdown in healthcare lending and overall deal activity [12][29] - The company executed three investments in existing portfolio companies totaling $50.7 million in funded loans during Q1 2025 [6][16] Company Strategy and Development Direction - The company aims to optimize its portfolio and enhance origination channels following the merger with BC Partners Credit, focusing on credit-first underwriting practices [6][9] - The strategic focus is on diversifying the portfolio and mitigating risks, with a target loan size range of $30 million to $150 million [6][9] - The company is positioned to benefit from a strategic focus on sustainable growth and a strong track record of low loss rates compared to peers [9][10] Management's Comments on Operating Environment and Future Outlook - Management noted a shift in the venture ecosystem, with companies now prioritizing sustainable growth over top-line growth due to market conditions [12][13] - The sentiment in the market is expected to shift, with companies needing to demonstrate growth to attract investment [14] - Management expressed confidence in the company's ability to cover dividends and build NAV per share, despite a cautious approach to credit [37][38] Other Important Information - The company has a total available liquidity of $315.4 million, including unrestricted cash and cash equivalents, and a borrowing capacity of $297 million [20] - A new stock repurchase program of $25 million was approved, reflecting management's confidence in the stock's valuation [22] - A regular distribution of $0.33 per share and a supplemental dividend of $0.02 per share were declared for Q2 2025 [23] Q&A Session Summary Question: Comments on healthcare lending and its slowdown - Management indicated that healthcare remains a core vertical but noted a softer quarter in lending, influenced by broader market conditions [28][29] Question: Update on the investment pipeline - The pipeline is currently seeing a mix of refinances and new opportunities, with a cautious approach to credit impacting activity levels [30][33] Question: Trends in net investment income and dividend declaration - The supplemental dividend for Q2 is lower due to a strategic decision to build NAV rather than focus solely on dividend payouts [36][38] Question: Impact of private credit market conditions - Management noted improvements in the structure of the pipeline, with lower leverage asks and maintained quality of covenants [44][45] Question: Insights on AI investment opportunities - The company is focused on mature businesses in the AI space, avoiding early-stage companies due to their high burn rates [46][48] Question: Factors driving realized gains and unrealized depreciation - Realized gains were driven by the sale of Gynasonics, while unrealized depreciation was influenced by performance and market multiples [51][53]